全国儿童SLC6A1基因疗法初显成效
Nationwide Children’s SLC6A1 gene therapy shows early promise
生物技术与制药领域的最新动态
Nationwide Children’s SLC6A1 gene therapy shows early promise
BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?
AR degradation inducers disclosed in Qingdao Putaike Biomedical patent
Genescience discovers new salts of MC4 receptor antagonists
FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center
ARCH, Lilly Asia Ventures return to back US-China startup SciNeuro
Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen
How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks? - Yahoo Finance
How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks? - Barchart.com
How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks? - Markets Financial Content
Paradigm Health, seeking to use AI to enroll clinical trials, partners with Roche - statnews.com
Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron - Endpoints News
Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron
Will Waters Corporation (WAZ) stock beat value stocks - July 2025 Market Mood & Target Return Focused Picks - Newser
Morgan Stanley Keeps Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Why Waters Corporation stock stays resilient - 2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - Newser
Stocks To Watch: 10x Genomics Sees Relative Strength Rating Rise To 91 - MSN
Why Waters Corporation stock remains undervalued - Earnings Overview Summary & Free High Accuracy Swing Entry Alerts - Newser
Breath Diagnostics completes install of advanced mass spectrometry system - Mugglehead Magazine
Breath Diagnostics completes install of advanced mass spectrometry system - Mugglehead Magazine